Header Logo

Connection

JENNIFER WHITAKER to Aged

Back to Details
This is a "connection" page, showing publications JENNIFER WHITAKER has written about Aged.
JENNIFER WHITAKER
Connection Strength
0.426
Aged
  1. The humoral immune response to high-dose influenza vaccine in persons with monoclonal B-cell lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL). Vaccine. 2021 02 12; 39(7):1122-1130.
    View in: PubMed
    Score: 0.053
  2. Strategies to maximize influenza vaccine impact in older adults. Vaccine. 2018 09 25; 36(40):5940-5948.
    View in: PubMed
    Score: 0.045
  3. Severe destructive nasopharyngeal granulomatosis with polyangiitis with superimposed skull base Pseudomonas aeruginosa osteomyelitis. BMJ Case Rep. 2017 Jul 19; 2017.
    View in: PubMed
    Score: 0.041
  4. INSIGHT FLU005: An Anti-Influenza Virus Hyperimmune Intravenous Immunoglobulin Pilot Study. J Infect Dis. 2016 Feb 15; 213(4):574-8.
    View in: PubMed
    Score: 0.036
  5. Prevalence and incidence of latent tuberculosis infection in georgian healthcare workers. PLoS One. 2013; 8(3):e58202.
    View in: PubMed
    Score: 0.031
  6. Homologous and Heterologous Covid-19 Booster Vaccinations. N Engl J Med. 2022 03 17; 386(11):1046-1057.
    View in: PubMed
    Score: 0.028
  7. Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase. N Engl J Med. 2021 Nov 04; 385(19):1774-1785.
    View in: PubMed
    Score: 0.028
  8. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med. 2021 02 04; 384(5):403-416.
    View in: PubMed
    Score: 0.026
  9. Remdesivir for the Treatment of Covid-19 - Final Report. N Engl J Med. 2020 11 05; 383(19):1813-1826.
    View in: PubMed
    Score: 0.026
  10. COVID-19 Vaccine Efficacy in Participants With Weakened Immune Systems From 4 Randomized Controlled Trials. Clin Infect Dis. 2024 08 16; 79(2):364-374.
    View in: PubMed
    Score: 0.017
  11. Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico. N Engl J Med. 2022 Feb 10; 386(6):531-543.
    View in: PubMed
    Score: 0.014
  12. Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosis. Am J Hematol. 2022 01 01; 97(1):90-98.
    View in: PubMed
    Score: 0.014
  13. Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial. Lancet Respir Med. 2021 12; 9(12):1365-1376.
    View in: PubMed
    Score: 0.014
  14. Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19. N Engl J Med. 2021 03 04; 384(9):795-807.
    View in: PubMed
    Score: 0.013
  15. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube Interferon Gamma Release Assays in Patients at Risk for Tuberculosis and in Health Care Workers. J Clin Microbiol. 2018 07; 56(7).
    View in: PubMed
    Score: 0.011
  16. Varicella-Zoster Virus-Specific Cellular Immune Responses to the Live Attenuated Zoster Vaccine in Young and Older Adults. J Immunol. 2017 07 15; 199(2):604-612.
    View in: PubMed
    Score: 0.010
  17. Metabolic Phenotypes of Response to Vaccination in Humans. Cell. 2017 May 18; 169(5):862-877.e17.
    View in: PubMed
    Score: 0.010
  18. Catheter Salvage After Catheter-Related Bloodstream Infection During Home Parenteral Nutrition. JPEN J Parenter Enteral Nutr. 2017 03; 41(3):481-488.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.